Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: Impact on clinical populations

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 8, 2014, Pages 1137-1141

  Cavalier, Etienne ^a   Delanaye, Pierre ^a   Lukas, Pierre ^a   Carlisi, Agnes ^a   Gadisseur, Romy ^a   Souberbielle, Jean Claude ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

chronic kidney disease; International Standard; parathormone; standardization

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CALIBRATION; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY ANALYZER; INTERNATIONAL STANDARD UNIT; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE ASSAY; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION; BLOOD; MIDDLE AGED; RENAL REPLACEMENT THERAPY; STANDARD; STANDARDS;

FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; REFERENCE STANDARDS; RENAL DIALYSIS;

EID: 84904003954     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-1027     Document Type: Article

References (13)

1. Souberbielle JC, Friedlander G, Cormier C. Practical considerations in PTH testing. Clin Chim Acta 2006;366:81-9.
2. Murray TM, Rao LG, Divieti P, Bringhurst FR. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev 2005;26:78-113.
3. D'Amour P, Brossard JH. Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology. Curr Opin Nephrol Hypertens 2005;14:330-6.
4. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 1998;44:805-9.
5. Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006;70:345-50.
6. Hecking M, Kainz A, Bielesz B, Plischke M, Beilhack G, Hörl WH, et al. Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients. Clin Biochem 2012;45:1645-51.
7. Cavalier E, Delanaye P, Hubert P, Krzesinski JM, Chapelle JP, Rozet E. Estimation of the stability of parathyroid hormone when stored at-80 degrees C for a long period. Clin J Am Soc Nephrol 2009;4:1988-92.
8. Horowitz GL. Defining, establishing and verifying reference intervals in clinical laboratory; approved guideline, 3rd ed. Wayne, PA: CLSI, 2008.
9. Sturgeon CM, Sprague SM, Metcalfe W. Variation in parathyroid hormone immunoassay results-A critical governance issue in the management of chronic kidney disease. Nephrol Dial Transplant 2011;26:3440-5.
10. Almond A, Ellis AR, Walker SW. Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease. Ann Clin Biochem 2012;49:63-7.
11. Kumar V, Barnidge DR, Chen LS, Twentyman JM, Cradic KW, Grebe SK, et al. Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin Chem 2010;56:306-13.
12. Miller WG, Myers GL, Rej R. Why commutability matters. Clin Chem 2006;52:553-4.
13. Marcus R, Madvig P, Young G. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. J Clin Endocrinol Metab 1984;58:223-30.